City
Epaper

India's bioeconomy sees 16-fold rise to reach $165.7 billion in 10 years: Minister

By IANS | Updated: March 21, 2025 17:46 IST

New Delhi, March 21 India's bioeconomy has witnessed 16-fold rise in the last 10 years -- from $10 ...

Open in App

New Delhi, March 21 India's bioeconomy has witnessed 16-fold rise in the last 10 years -- from $10 billion in 2014 to an impressive $165.7 billion in 2024, the government said on Friday.

This exponential growth is a testament to the government's commitment to fostering biotechnology as a key pillar of India's future economic growth, said Union Minister Dr Jitendra Singh at the BIRAC Foundation Day ceremony in the national capital.

"In just 10 years, India's bio-economy has expanded from a modest $10 billion to $165.7 billion, far surpassing our initial target of $150 billion by 2025," Dr Singh stated, quoting the ‘IBER 2025’ report.

As per the report, the sector is contributing 4.25 per cent to the overall GDP. The sector has shown a CAGR of 17.9 per cent over the past four years, showcasing India’s potential as a global biotech powerhouse.

The minister also unveiled BioSaarthi, a pioneering global mentorship initiative aimed at nurturing biotech startups.

Designed as a six-month cohort, BioSaarthi will facilitate structured mentor-mentee engagements, offering personalised guidance to emerging entrepreneurs in the biotech sector.

The minister emphasised that this initiative will strengthen India’s biotech ecosystem by fostering innovation, enhancing industry-academia collaboration, and positioning Indian startups for global success.

The initiative would engage overseas experts, particularly from Indian diaspora as international mentors who would volunteer to give back to the society.

The minister also highlighted the recently approved BIO-E3 Policy —Biotechnology for Economy, Employment, and Environment — which aims to accelerate research, innovation, and entrepreneurship in the sector.

Dr Singh also announced that Assam has become the first state to adopt the BioE3 framework, marking a significant step toward pan-India implementation. India’s biotech startup ecosystem has grown from just 50 startups a decade ago to over 10,075 now.

India's gross expenditure on research and development (GERD) has more than doubled in the past decade, rising from Rs 60,196 crore in 2013-14 to Rs 1,27,381 crore in 2024.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

NationalPetition filed in K'taka HC against govt move to have Booker Prize awardee Mushtaq inaugurate Mysuru Dussehra

NationalAfter Bihar, SIR likely to be conducted across country, ECI to hold a key meeting with all CEOs on Sep 10

EntertainmentBaaghi 4 Box Office Collection Day 1: Tiger Shroff's Film Earns Rs 12 Crore on Opening Day

EntertainmentAs Ananya Panday's Call Me Bae turns 1, actress says 'Can't wait to get back'

Cricket"Pant is only match winner": Former England cricketer Butcher feels India will miss 'match-winners' Rohit, Virat

Business Realted Stories

BusinessApple's India sales hit record $9 billion in FY25 after retail expansion

BusinessBernstein cautions Indian digital creators on possible re-entry of Chinese firms

BusinessImmigration crackdown at US battery plant: S. Korean foreign minister may visit US

BusinessUnion Minister Shri Bhupender Yadav Felicitates Lakhpati Winning Team of Sustainovation by Intin - India's Sustainability Hackathon

BusinessTCL Inspires Greatness at IFA 2025, Bringing Olympic Spirit to the Future of Technology